Inhibition of tibialis anterior spinal reflex circuits using frequency‐specific neuromuscular electrical stimulation
Artificial Organs · 2024
DOI: 10.1111/aor.14737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2024. Verfasst von Suzufumi Arai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Engineering Science, Department of Mechanical Science and Bioengineering, Osaka University, Toyonaka, Japan. Hauptthemen laut MEDLINE: Muscle, Skeletal, Reflex, Muscle Contraction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Buoniconti Fund to Cure Paralysis, JTEKT Corporation.
Abstract (Originalsprache)
Background
Neuromuscular electrical stimulation (NMES) can generate muscle contractions and elicit excitability of neural circuits. However, the optimal stimulation frequency for effective neuromodulation remains unclear.
Methods
Eleven able‐bodied individuals participated in our study to examine the effects of: (1) low‐frequency NMES at 25 Hz, (2) high‐frequency NMES at 100 Hz; and (3) mixed‐frequency NMES at 25 and 100 Hz switched every second. NMES was delivered to the right tibialis anterior (TA) muscle for 1 min in each condition. The order of interventions was pseudorandomized between participants with a washout of at least 15 min between conditions. Spinal reflexes were elicited using single‐pulse transcutaneous spinal cord stimulation applied over the lumbar enlargement to evoke responses in multiple lower‐limb muscles bilaterally and maximum motor responses ( M max ) were elicited in the TA muscle by stimulating the common peroneal nerve to assess fatigue at the baseline and immediately, 5, 10, and 15 min after each intervention.
Results
Our results showed that spinal reflexes were significantly inhibited immediately after the mixed‐frequency NMES, and for at least 15 min in follow‐up. Low‐frequency NMES inhibited spinal reflexes 5 min after the intervention, and also persisted for at least 10 min. These effects were present only in the stimulated TA muscle, while other contralateral and ipsilateral muscles were unaffected. M max responses were not affected by any intervention.
Conclusions
Our results indicate that even a short‐duration (1 min) NMES intervention using low‐ and mixed‐frequency NMES could inhibit spinal reflex excitability of the TA muscle without inducing fatigue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Engineering Science, Department of Mechanical Science and Bioengineering, Osaka University, Toyonaka, Japan.
- The Miami Project to Cure Paralysis, University of Miami, Miami, Florida, USA.
- Global Center for Medical Engineering and Informatics, Osaka University, Suita, Japan.
- Department of Neurological Surgery, University of Miami, Miami, Florida, USA.
- Department of Biomedical Engineering, University of Miami, Miami, Florida, USA.
ORCID-Profile: Atsushi Sasaki, Taishin Nomura, Matija Milosevic
Förderung
- Japan Society for the Promotion of Science
- Buoniconti Fund to Cure Paralysis
- JTEKT Corporation
- Florida Department of Health
Zitieren
APA
Arai, S., Sasaki, A., Tsugaya, S., Nomura, T., & Milosevic, M. (2024). Inhibition of tibialis anterior spinal reflex circuits using frequency‐specific neuromuscular electrical stimulation. Artificial Organs. https://doi.org/10.1111/aor.14737
Vancouver
Arai S, Sasaki A, Tsugaya S, Nomura T, Milosevic M. Inhibition of tibialis anterior spinal reflex circuits using frequency‐specific neuromuscular electrical stimulation. Artificial Organs. 2024. doi:10.1111/aor.14737
BibTeX
@article{Arai2024,
author = {Arai, Suzufumi and Sasaki, Atsushi and Tsugaya, Shota and Nomura, Taishin and Milosevic, Matija},
title = {Inhibition of tibialis anterior spinal reflex circuits using frequency‐specific neuromuscular electrical stimulation},
journal = {Artificial Organs},
year = {2024},
doi = {10.1111/aor.14737}
}
EUVIMED